AbCellera Biologics Inc. (ABCL) Net Income by Year
AbCellera Biologics Inc. reported a net loss of $146.4M in fiscal year 2025. This represents an increase of 10.1% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $164.7M net loss. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters AbCellera Biologics Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ABCL Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
ABCL Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More AbCellera Biologics Inc. financials
Frequently Asked Questions
What was AbCellera Biologics Inc.'s net income in fiscal year 2025?
AbCellera Biologics Inc. reported a net loss of $146.4M in fiscal year 2025.
How fast is AbCellera Biologics Inc.'s net income growing?
AbCellera Biologics Inc. (ABCL) net income rose by 10.1% year over year, from -$162.9M to -$146.4M in fiscal year 2025.
What is AbCellera Biologics Inc.'s net income over the last twelve months?
AbCellera Biologics Inc. (ABCL) reported a $164.7M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has AbCellera Biologics Inc.'s net income changed over the years?
Across the 7 fiscal years this page covers, AbCellera Biologics Inc. (ABCL) net income went from -$2.2M in fiscal year 2019 to -$146.4M in fiscal year 2025.
What was AbCellera Biologics Inc.'s net income in the most recent quarter?
AbCellera Biologics Inc. (ABCL) reported -$55.4M in net income in Q2 2026. This represents a decrease of 59.6% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what AbCellera Biologics Inc. (ABCL) reported on that line in every period on record.